Doxorubicin (Adriamycin)
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for Doxorubicin (Adriamycin), covering 2008-03-04 to 2025-06-24. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Trial of 4 vs 6 Cycles of CHP Combined With Polatuzumab Vedotin-Rituximab in Untreated DLBCL Patients With IPI 0-1 [Phase 2]